Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
31 participants
OBSERVATIONAL
2022-02-23
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Usefulness of Gadovist-enhanced FLAIR Imaging
NCT05293990
Non-invasive Glioma Characterization Through Molecular Imaging
NCT03684109
Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study
NCT01212731
Gene Expression, Immunological Status and Metabolome in Glioma Patients
NCT01525459
Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
NCT05911230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must be age \>= 18 years
* Patients must be able to obtain an MRI scan with gadolinium contrast
* Patients must sign informed consent indicating that they are aware of the investigational nature of this study:
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliero-Universitaria Careggi
OTHER
Azienda Ospedaliera di Padova
OTHER
Istituto Oncologico Veneto IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susanna Mandruzzato, PhD
Role: PRINCIPAL_INVESTIGATOR
Istituto Oncologico Veneto IOV-IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Florence, , Italy
University Hospital
Padua, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/27
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.